TSE:NBLY Neighbourly Pharmacy (NBLY) Stock Price, News & Analysis → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Free NBLY Stock Alerts Add Compare Share Share Today's Range N/A50-Day RangeC$18.24▼C$18.6052-Week Range N/AVolume816,808 shsAverage Volume283,112 shsMarket CapitalizationC$835.51 millionP/E RatioN/ADividend Yield0.98%Price TargetC$20.93 Stock AnalysisStock AnalysisAnalyst ForecastsChartDividendHeadlinesInsider TradesStock AnalysisAnalyst ForecastsChartDividendHeadlinesInsider Trades Get Neighbourly Pharmacy alerts: Email Address Ad DTIA new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… Click here to see me place one of these trades LIVE on camera. About Neighbourly Pharmacy Stock (TSE:NBLY)Neighbourly Pharmacy Inc. owns and operates a chain of retail pharmacies in Canada. The company sells prescription medication, confections and food, over the counter drugs, and health and beauty aids. It operates pharmacies under the various banners, such as IDA/Guardian, Pharmachoice, Pharmasave, Remedy's RX, and Drug Trading. The company was incorporated in 2015 and is headquartered in Toronto, Canada.Read More Ad DTIA new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… Click here to see me place one of these trades LIVE on camera. NBLY Stock News HeadlinesMarch 23, 2024 | finanznachrichten.deNeighbourly Pharmacy Inc.: Neighbourly Announces Successful Closing of Take-Private Transaction with Persistence Capital PartnersMarch 21, 2024 | finanznachrichten.deNeighbourly Pharmacy Inc.: Neighbourly Receives Final Court Approval of Plan of Arrangement to be Acquired by Persistence Capital PartnersApril 23, 2024 | WealthPress (Ad)$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…March 20, 2024 | finance.yahoo.comNeighbourly Announces Successful Closing of Take-Private Transaction with Persistence Capital PartnersMarch 19, 2024 | finance.yahoo.comNeighbourly Pharmacy Inc.'s (TSE:NBLY) largest shareholders are private equity firms with 50% ownership, individual investors own 36%March 14, 2024 | finance.yahoo.comNeighbourly Receives Final Court Approval of Plan of Arrangement to be Acquired by Persistence Capital PartnersMarch 8, 2024 | marketwatch.comNeighbourly Pharmacy Holders Approve Deal to go PrivateMarch 8, 2024 | finance.yahoo.comNeighbourly Obtains Shareholder Approval for Going Private Transaction with Persistence Capital PartnersApril 23, 2024 | Crypto 101 Media (Ad)SHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. February 16, 2024 | ca.finance.yahoo.comNeighbourly Pharmacy Inc. (NBLY.TO)February 15, 2024 | finance.yahoo.comWhen Will Neighbourly Pharmacy Inc. (TSE:NBLY) Breakeven?February 13, 2024 | msn.comNeighbourly Pharmacy Inc. Non-GAAP EPS of C$0.19, revenue of C$284MFebruary 13, 2024 | finance.yahoo.comNeighbourly Announces Strong Third Quarter ResultsFebruary 12, 2024 | finance.yahoo.comNeighbourly Announces Filing of Special Meeting Materials and Receipt of Interim Order in Respect of Go-Private Arrangement with Persistence Capital PartnersFebruary 1, 2024 | finance.yahoo.comNeighbourly Announces Timing of Third Quarter 2024 Earnings ReleaseJanuary 23, 2024 | finance.yahoo.comNeighbourly Appoints Maura Dyer as Senior Vice President, People and CultureJanuary 15, 2024 | marketwatch.comNeighbourly Pharmacy Shares Rise 16% on Go-Private DealJanuary 15, 2024 | marketwatch.comNeighbourly Pharmacy Agrees to Go-Private Deal Worth C$415MJanuary 15, 2024 | msn.comPersistence Capital Partners signs deal to take Neighbourly Pharmacy privateJanuary 15, 2024 | finance.yahoo.comNeighbourly Enters into Definitive Agreement to go Private with its Controlling Shareholder Persistence Capital PartnersDecember 20, 2023 | theglobeandmail.comClosing Bell: Neighbourly Pharmacy Inc up on Wednesday (NBLY)December 19, 2023 | finance.yahoo.comNeighbourly Pharmacy's Market Cap Drops To CA$800m Leaving Insiders With LossesDecember 18, 2023 | theglobeandmail.comPersistence Capital Partners cuts buyout offer for Neighbourly PharmacyDecember 18, 2023 | marketwatch.comToronto Stocks Climb; Neighbourly Pharmacy Falls on Lowered Buyout OfferDecember 18, 2023 | marketwatch.comNeighbourly Pharmacy Shares Slide 12% on Lowered Buyout Price ProposalDecember 18, 2023 | finance.yahoo.comNeighbourly Provides Update on Proposal from Persistence Capital PartnersDecember 18, 2023 | finance.yahoo.comPersistence Capital Partners Proposes Fully Financed Offer to Take Neighbourly Private at $18.50 per ShareSee More Headlines Receive NBLY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Neighbourly Pharmacy and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/23/2024Next Earnings (Estimated)6/06/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Pharmaceutical Retailers Sub-IndustryN/A Current SymbolTSE:NBLY CUSIPN/A CIKN/A Webneighbourlypharmacy.ca Phone416 309 9102FaxN/AEmployees3,648Year FoundedN/APrice Target and Rating Average Stock Price TargetC$20.93 High Stock Price TargetC$28.00 Low Stock Price TargetC$18.50 Consensus RatingHold Rating Score (0-4)2.40 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)C($0.73) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-32,700,000.00 Net Margins-3.74% Pretax MarginN/A Return on Equity-5.34% Return on Assets0.74% Debt Debt-to-Equity Ratio58.29 Current Ratio1.14 Quick Ratio0.75 Sales & Book Value Annual SalesC$874.61 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow31.16 Book ValueC$13.07 per share Price / BookN/AMiscellaneous Outstanding Shares44,920,000Free FloatN/AMarket CapC$835.51 million OptionableNot Optionable Beta0.29 These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesMr. Skip Bourdo (Age 46)CEO & Director Comp: $604.17kMr. Billy Wong C.M.A.CPA, M.B.A., Chief Financial OfficerMr. Jari Pekka Villanen (Age 53)Senior Vice President of Integration, Real Estate & Central Operations Comp: $307.48kMr. Steve Losty (Age 50)Chief Development Officer Comp: $302.15kMs. Maura DyerSenior Vice President of People & CultureMs. Alicia Matthews-KentSenior Vice President of Pharmacy Strategy & National OperationsMr. Zev ZelmanCorporate SecretaryMore ExecutivesKey CompetitorsCanopy GrowthTSE:WEEDWELL Health TechnologiesTSE:WELLSienna Senior LivingTSE:SIAHydropothecaryCVE:THCXExtendicareTSE:EXEView All CompetitorsInsidersRx Sidecar GP Inc.Bought 62,500 shares on 3/11/2024Total: C$1.16 M ($18.53/share)Stephen Richard LostySold 3,033 sharesTotal: C$55,685.88 ($18.36/share)Stephen Richard LostySold 2,711 sharesTotal: C$42,860.91 ($15.81/share)Stephen Richard LostySold 22,767 sharesTotal: C$404,489.91 ($17.77/share)View All Insider Transactions NBLY Stock Analysis - Frequently Asked Questions Should I buy or sell Neighbourly Pharmacy stock right now? 5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Neighbourly Pharmacy in the last twelve months. There are currently 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" NBLY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NBLY, but not buy additional shares or sell existing shares. View NBLY analyst ratings or view top-rated stocks. What is Neighbourly Pharmacy's stock price target for 2024? 5 brokerages have issued 12 month target prices for Neighbourly Pharmacy's stock. Their NBLY share price targets range from C$18.50 to C$28.00. On average, they predict the company's share price to reach C$20.93 in the next twelve months. View analysts price targets for NBLY or view top-rated stocks among Wall Street analysts. When is Neighbourly Pharmacy's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, June 6th 2024. View our NBLY earnings forecast. How often does Neighbourly Pharmacy pay dividends? What is the dividend yield for Neighbourly Pharmacy? Neighbourly Pharmacy announced a quarterly dividend on Monday, November 20th. Investors of record on Tuesday, December 19th will be paid a dividend of 0.045 per share on Tuesday, December 19th. This represents a $0.18 dividend on an annualized basis and a dividend yield of ∞. The ex-dividend date of this dividend is Monday, November 20th. Read our dividend analysis for NBLY. Is Neighbourly Pharmacy a good dividend stock? Neighbourly Pharmacy (TSE:NBLY) pays an annual dividend of C$0.18 per share and currently has a dividend yield of 0.98%. Read our dividend analysis for NBLY. How do I buy shares of Neighbourly Pharmacy? Shares of NBLY stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (TSE:NBLY) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 Mediatop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingMan Who Predicted 2008: “This Will be Worse.”AltimetryExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersGreat Crypto BullWeiss RatingsThe Next Nvidia?InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neighbourly Pharmacy Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
